Resources

Past Presentation

MAT and the HCV Provider | March 23, 2022

Date of Presentation: March 23, 2022

Type: Past Presentation  

Program: Hepatitis C  

Keywords: #harm reduction  #hcv treatment  #mat  #OUD  #SUD  

In this presentation Dr. Jessica Gregg provides an overview of screening, treatment options, and individualized care for patients with substance use disorder and hepatitis C virus. The trifecta of interventions needed include treating the HCV infection with antivirals, decreasing the risk of injecting with medications for substance use disorder, and decreasing risk of infection with safe syringe and harm reduction programs.

Recording:

Presented by:

Dr. Jessica Gregg

Jessica Gregg, MD, PhD, received her undergraduate degree at Stanford University, her medical degree at the University of New Mexico, and a PhD in Medical Anthropology at Emory University. She began her medical career in primary care at Oregon Health and Science University (OHSU), where she co-founded the OHSU Department of Medicine’s Social Medicine curriculum in partnership with City Central Concern, a non-profit caring for individuals struggling with lack of housing and substance use disorders. She subsequently became the medical director for Central City Concern’s Hooper Detoxification and Stabilization Center, and eventually assumed the role of Senior Medical Director for Substance Use Disorder Services for the agency. She subsequently developed the HRBR clinic at OHSU, a low-threshold buprenorphine clinic, and in 2021, she became Chief Medical Officer for Fora Health in Portland, Oregon.

Resources Provided:

Date added: March 23, 2022